疏忽
发表于 2025-3-26 23:59:59
Artificial Intelligence for Vaccine Designe in bioinformatics as AI allows for new and increasingly powerful ways of understanding genomics, proteomics, and immunology, just to name a few areas. Also exciting is a parallel growth in high-throughput assays including sequencing which will further accelerate the development and use of AI in bi
ALLEY
发表于 2025-3-27 04:16:48
http://reply.papertrans.cn/99/9802/980187/980187_32.png
Confirm
发表于 2025-3-27 07:59:04
Polymer–Peptide Conjugate Vaccine for Oral Immunizationstry, and polymer science for the conjugation of molecular entities of all sizes. In this protocol, B-cell epitope J8, derived from group A . (GAS) M protein, and universal T-helper epitope PADRE were conjugated to poly(methyl acrylate) (PMA) to form a self-assembled nanoparticle vaccine candidate (
铺子
发表于 2025-3-27 11:36:38
An Update on “Reverse Vaccinology”: The Pathway from Genomes and Epitope Predictions to Tailored, Rees to develop vaccines based on the concept of reverse vaccinology. They all follow the same basic principles—mining available genome and proteome information for antigen candidates, and recombinantly expressing them for vaccine production. Some of the same principles have been used successfully for
obviate
发表于 2025-3-27 16:38:29
Phage T7 as a Potential Platform for Vaccine Developmentteriophage T7 has been demonstrated to be useful in the production of potential vaccine candidates for various diseases, including influenza A, foot-and mouth disease (FMD), and cancers. In this chapter, we described the use of phage T7 to display potential foot-and-mouth disease virus (FMDV) epitop
Panacea
发表于 2025-3-27 21:13:13
Plant-Based Systems for Vaccine Productionsuggests that plants display several key advantages over existing traditional platforms when they are intended for therapeutic uses, including safety, scalability, and the speed in obtaining the final product..Here, we describe a method that could be applied for the expression and production of a ca
蒙太奇
发表于 2025-3-27 22:43:34
Production of a Hepatitis E Vaccine Candidate Using the , Expression System particularly severe among pregnant women (20–30% mortality). No vaccine is available to combat the HEV except Hecolin, which is available only in China. Virus-like particle (VLP) generated from the capsid protein (ORF2) of HEV is known to be a potent vaccine antigen against HEV. Hecolin consists of
预兆好
发表于 2025-3-28 04:23:53
http://reply.papertrans.cn/99/9802/980187/980187_38.png
Initiative
发表于 2025-3-28 08:06:02
Adjuvants: Engineering Protective Immune Responses in Human and Veterinary Vaccinestection from the associated disease. In recent years, advances in our understanding of the innate and adaptive immune systems have allowed for the development of a number of novel adjuvants with differing mechanisms of action. Herein, we review adjuvants currently approved for human and veterinary u
PLAYS
发表于 2025-3-28 11:33:28
Cationic Nanostructures as Adjuvants for Vaccines proteins, peptides, nucleic acids, or oligonucleotides. This report provides instructions for the preparation and physical characterization of four different cationic nanostructures able to combine and deliver antigens to the immune system: (1) dioctadecyl dimethylammonium bromide (DODAB) bilayer f